Better IVF
Interactive data explorer

Growth hormone for IVF, in women 40 and over

Move through the ages and see what the trials actually show about adding growth hormone (HGH) in IVF.

Better IVF, interactive evidence

Growth hormone for IVF, in women 40 and over

Growth hormone (GH, or HGH) is sometimes added to the normal IVF stimulation drugs, usually for older women or poor responders. Any single trial has been small, so the useful evidence is a 2023 meta-analysis that pooled them and, importantly, isolated women aged 40 and over. Here is what it found, why the size looks big, and the honest caveat. A companion study on embryo euploidy is shown too, and every figure is labelled with its source.

The pooled result

Adding GH, in women 40 and over

2023 meta-analysis

These are odds ratios, a relative measure. An odds ratio of 2 means about twice the odds, not twice the rate. On a low older-women baseline, that is still a large lift.

2.2x
the odds of a clinical pregnancy with GH
odds ratio 2.2 (95% CI 1.34 to 3.61), statistically significant
4.1x
the odds of a live birth with GH
odds ratio 4.12 (95% CI 1.82 to 9.32), statistically significant
When one outlier trial is removed, the clinical-pregnancy result gets cleaner, not weaker (odds ratio 2.77, with zero measured heterogeneity). So the effect is not resting on a single odd study.
The likely mechanism

Embryo euploidy in advanced maternal age

companion study

A separate study in older women found GH was linked to a higher share of chromosomally normal (euploid) blastocysts, the plausible reason for the live-birth lift above.

Without GH
about 20%
With GH
about 35%
Euploid rate rising from about 20% to about 35% is a relative increase of about 75%, on the exact thing that limits older women. Promising, and it needs randomised confirmation.
The dose, so you can discuss it

What the trials actually used

across the trials

IU means International Units, a measure of biological activity. For growth hormone, roughly 3 IU is about 1 milligram. Doses varied a lot; here are the two patterns to raise with a clinic.

For embryo quality
about 2 IU per day
Lower and longer: started the menstrual cycle before stimulation. This is the pattern the euploidy study used.
For response within a cycle
about 4 to 8 IU per day
Higher and shorter: started around the beginning of stimulation, continued to the trigger.
Directional only, to discuss with your own clinic, not a prescription. GH is an off-label IVF add-on; your doctor decides dose and suitability.
Read this before you get excited

The honest caveat

The individual trials are small, some with very few events, and most of the original papers sit behind paywalls, so the pooled numbers come from the meta-analysis's own extracted data. Odds ratios also overstate the effect versus plain rate differences on a low baseline. This is a large, promising, older-women-specific signal that deserves a real conversation with a clinic, not a proven protocol.